IceCure Medical (ICCM) News Today $0.60 -0.01 (-1.63%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period IceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024November 20 at 8:30 AM | prnewswire.comIceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of HealthNovember 19 at 8:30 AM | prnewswire.comHC Wainwright Reaffirms Buy Rating for IceCure Medical (NASDAQ:ICCM)November 12, 2024 | americanbankingnews.comIceCure's ProSense System Gets FDA Panel's Favorable Vote For Low Risk Breast Cancer TreatmentNovember 8, 2024 | markets.businessinsider.comFDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast CancerNovember 8, 2024 | prnewswire.comUpcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from StakeholdersOctober 29, 2024 | prnewswire.comIceCure Medical Expands Patent Portfolio with New US ApprovalOctober 22, 2024 | markets.businessinsider.comIceCure Medical granted patent by USPTO for cryoablation systemOctober 22, 2024 | markets.businessinsider.comIceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation SystemOctober 21, 2024 | prnewswire.comIcecure Medical: A Strong Buy on Clinical Success and Upcoming Regulatory CatalystsOctober 13, 2024 | markets.businessinsider.comIcecure Medical (NASDAQ:ICCM) Stock Quotes, Forecast and News SummaryOctober 9, 2024 | benzinga.comIcecure Medical (NASDAQ:ICCM) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comIceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging ConferenceOctober 7, 2024 | prnewswire.comIceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24, 2024 | prnewswire.comStudy Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft TissuesSeptember 16, 2024 | prnewswire.comIceCure Medical’s ProSense Positioned for Market Success Following FDA Panel Meeting, Analyst Maintains Buy RatingSeptember 13, 2024 | markets.businessinsider.comFDA AdComm to discuss IceCure's ProSense on Nov. 7September 12, 2024 | msn.comIceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024September 12, 2024 | prnewswire.comIceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets ConferencesSeptember 4, 2024 | prnewswire.comUSPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation TechnologiesAugust 28, 2024 | prnewswire.comIcecure Medical Poised for Growth: A Comprehensive Buy RecommendationAugust 22, 2024 | markets.businessinsider.comIcecure Medical: A Strong Buy on Robust Financials and Regulatory AdvancementsAugust 21, 2024 | markets.businessinsider.comIceCure Medical Ltd (NASDAQ:ICCM) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | msn.comIceCure Medical Reports 20% Growth in ProSense® System and Probe Sales for the First Half of 2024; Reflects Continued Adoption in the U.S. and Other Global MarketsAugust 20, 2024 | prnewswire.comIceCure's ProSense® Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of SurgeryAugust 14, 2024 | prnewswire.comIceCure Medical to Report Second Quarter 2024 Financial & Operational Results on August 20, 2024August 13, 2024 | prnewswire.comIceCure Announces Positive Data from the Largest Multi-Institutional Study of its Kind: "Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials"August 7, 2024 | prnewswire.comIceCure Medical receives Nasdaq compliance noticeJuly 22, 2024 | finance.yahoo.com99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer SocietyJuly 22, 2024 | prnewswire.comIceCure Medical Announces Receipt of Nasdaq Minimum Bid Price NotificationJuly 19, 2024 | prnewswire.comEuropean Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast CancerJuly 9, 2024 | prnewswire.comU.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbesJuly 1, 2024 | prnewswire.comIceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024June 18, 2024 | prnewswire.comPositive Data from IceCure's Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal FunctionJune 12, 2024 | prnewswire.comFDA to Convene Advisory Panel for Review of IceCure's De Novo Marketing Clearance Request for ProSense®, Decision Expected Early 2025; Aligns with Commercial Readiness PlanJune 4, 2024 | prnewswire.comIceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024May 28, 2024 | prnewswire.comIceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024May 21, 2024 | prnewswire.comIceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024May 21, 2024 | prnewswire.comIceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners' Virtual Healthcare Company ShowcaseMay 20, 2024 | prnewswire.comHere's Why It's Unlikely That IceCure Medical Ltd's (NASDAQ:ICCM) CEO Will See A Pay Rise This YearMay 14, 2024 | finance.yahoo.comIndependent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published GloballyMay 7, 2024 | prnewswire.comHofseth Biocare ASA: HBC ANNUAL REPORT 2023April 19, 2024 | finance.yahoo.comIceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast CancerApril 15, 2024 | finance.yahoo.comIcecure Medical: Strong Buy on Impressive Q4 Revenue and Promising Regulatory MilestonesApril 6, 2024 | markets.businessinsider.comIceCure Medical Ltd. (ICCM) Q4 2023 Earnings Call TranscriptApril 5, 2024 | seekingalpha.comIceCure seeks FDA clearance for new cryoablation systemApril 4, 2024 | uk.investing.comIceCure Medical (NASDAQ:ICCM) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPSIceCure Medical (NASDAQ:ICCM - Get Free Report) released its earnings results on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.01. The business had revenue of $1.26 million during the quarter. IceCure Medical had a negative return on equity of 77.41% and a negative net margin of 535.84%. During the same period in the prior year, the business earned ($0.11) earnings per share.April 4, 2024 | marketbeat.comIceCure Medical (NASDAQ:ICCM) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and issued a $3.00 target price on shares of IceCure Medical in a report on Thursday.April 4, 2024 | marketbeat.comIceCure Medical Reports Full Year 2023 Financial Results: Global ProSense® and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast Cancer Study Data to FDA this Month for Marketing ClearanceApril 3, 2024 | prnewswire.comIceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with CryoprobesApril 2, 2024 | prnewswire.com Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. ICCM Media Mentions By Week ICCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICCM News Sentiment▼0.000.45▲Average Medical News Sentiment ICCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICCM Articles This Week▼21▲ICCM Articles Average Week Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QIPT News INO News GUTS News LNSR News MODD News MGRM News NSPR News TMDIF News LUCD News HSAQ News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICCM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
